Genscript Biotech Corp operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Genscript Biotech Corp with three other miscellaneous service companies in Asia: Shin Nippon Biomedical Laboratories Ltd of Japan (2017 sales of 17.24 billion Japanese Yen [US$155.89 million] of which 75% was Pre-Clinical Business), Syngene International Ltd of India (12.01 billion Indian Rupees [US$168.25 million] ), and Sosei Group Corporation which is based in Japan (18.90 billion Japanese Yen [US$170.87 million] of which 99% was Overseas Pharmaceutical Business).

Sales Analysis. During the year ended December of 2017, sales at Genscript Biotech Corp were HK$1.19 billion (US$151.61 million). This is an increase of 33.6% versus 2016, when the company's sales were HK$890.52 million. This was the fifth consecutive year of sales increases at Genscript Biotech Corp (and since 2012, sales have increased a total of 190%). Sales of Industrial Synthetic Biology Products saw an increase that was more than double the company's growth rate: sales were up 69.0% in 2017, from HK$54.36 million to HK$91.89 million.